Search

Your search keyword '"Blanco, Julià"' showing total 855 results

Search Constraints

Start Over You searched for: Author "Blanco, Julià" Remove constraint Author: "Blanco, Julià"
855 results on '"Blanco, Julià"'

Search Results

1. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

2. Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

3. A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

4. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

6. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

7. An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

11. T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG

12. TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses

13. β-Cyclodextrins as affordable antivirals to treat coronavirus infection

14. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates

15. Macrophage CD5L is a target for cancer immunotherapy

16. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

17. Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

18. HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights

19. Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals

22. Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

23. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission

24. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

25. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

27. Detection of SARS-CoV-2 in a cat owned by a COVID-19–affected patient in Spain

28. SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

35. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.

36. Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.

37. Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial

38. Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

39. Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

41. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

42. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

43. Autophagy and HIV Infection

44. Organisational LCA

47. Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals

48. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

49. VLP-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

Catalog

Books, media, physical & digital resources